European Society for Medical Oncology (ESMO) shared on LinkedIn:
“ESMONovelTherapies27: Novel therapies are changing oncology. The real question is: how do we optimise their use in practice?
As new therapeutic modalities move rapidly from development into routine care, clinicians need more than an understanding of what’s new.
They need to know:
- How do these therapies work?
- Which patients are most likely to benefit?
- Where do they fit in the treatment sequence?
- How can treatment-related toxicities be managed effectively?
This programme brings together the pharmacological and biological principles, clinical evidence and practical considerations needed to translate novel approved therapies into better patient care.
Whether you’re looking to deepen your understanding of emerging treatment strategies, refine your clinical decision-making or stay ahead of the evolving oncology landscape, this programme is designed for you.
Join the discussion and register by 13 January to benefit from the most advantageous fees.”
Other articles about European Society for Medical Oncology on OncoDaily.